EL7.AI
StocksMedium•17 November 2026•
1 min read

Louisiana Appeals Court Upholds Verdict Against Johnson & Johnson in Talc Litigation

Key Facts

1A Louisiana appeals court upheld a multimillion-dollar verdict against Johnson & Johnson, finding its talc powder caused a woman's mesothelioma and death.

A Louisiana appeals court upheld a multimillion-dollar verdict against Johnson & Johnson regarding the death of a woman from mesothelioma. Business Wire reported that the court found the company's talc powder responsible for the illness and subsequent death of a New Orleans resident, leading the appellate court to affirm and increase the damages awarded by a trial court.

Johnson & Johnson, trading under the ticker JNJ, was trading at $280.56 on November 17, 2026. The stock reached a session high of $281.72 and a low of $277.56 on November 17, 2026, as the company continues to manage persistent liability risks and legal challenges stemming from its talc-based products.

Open on chart